Infection transmission and chronic disease models in the study of infection-associated cancers

British Journal of Cancer

Volumn 110, Issue 1, 2014, Pages 7-11

  Baussano, I ^a   Franceschi, S ^a   Plummer, M ^a  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

Author keywords

cancer epidemiology; infectious diseases epidemiology; mathematical model

Indexed keywords

CANCER MODEL; CARCINOGENESIS; DISEASE TRANSMISSION; EMPIRICAL RESEARCH; EPIDEMIC; INTEGRATION; NONHUMAN; PRIORITY JOURNAL; REVIEW;

CHRONIC DISEASE; EPIDEMIOLOGIC METHODS; HUMANS; INFECTION; MODELS, STATISTICAL; NEOPLASMS;

EID: 84891885249     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2013.740     Document Type: Review

References (32)

1. Anderson RM, May RM (1991) Infectious-Diseases of Humans-Dynamics and Control. Oxford University Press: New York, USA.
2. Barnabas RV, Laukkanen P, Koskela P, Kontula O, Lehtinen M, Garnett GP (2006) Epidemiology of HPV 16 and cervical cancer in Finland and the potential impact of vaccination: mathematical modelling analyses. PLoS Med 3: e138.
3. Baussano I, Lazzarato F, Ronco G, Dillner J, Franceschi S (2013) Benefits of catch-up in vaccination against human papillomavirus in medium-and low-income countries. Int J Cancer 133: 1876-1881.
4. Baussano I, Ronco G, Segnan N, French K, Vineis P, Garnett GP (2010) HPV-16 infection and cervical cancer: modeling the influence of duration of infection and precancerous lesions. Epidemics 2: 21-28.
5. Boily MC, Baggaley RF, Wang L, Masse B, White RG, Hayes RJ, Alary M (2009) Heterosexual risk of HIV-1 infection per sexual act: systematic review and meta-analysis of observational studies. Lancet Infect Dis 9: 118-129.
6. Box GEP, Draper NR (1987) Empirical Model Building and Response Surfaces. John Wiley & Sons.
7. Burchell AN, Richardson H, Mahmud SM, Trottier H, Tellier PP, Hanley J, Coutlee F, Franco EL (2006) Modeling the sexual transmissibility of human papillomavirus infection using stochastic computer simulation and empirical data from a cohort study of young women in Montreal, Canada. Am J Epidemiol 163: 534-543.
8. Bureau A, Shiboski S, Hughes JP (2003) Applications of continuous time hidden Markov models to the study of misclassified disease outcomes. Stat Med 22: 441-462. (Pubitemid 36163597)
9. De Martel C, Ferlay J, Franceschi S, Vignat J, Bray F, Forman D, Plummer M (2012) Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. Lancet Oncol 13: 607-615.
10. Garnett GP (2005) Role of herd immunity in determining the effect of vaccines against sexually transmitted disease. J Infect Dis 191(Suppl 1): S97-S106. (Pubitemid 40144234)
11. Garnett GP, Anderson RM (1994) Balancing sexual partnerships in an age and activity stratified model of HIV transmission in heterosexual populations. IMA J Math Appl Med Biol 11: 161-192. (Pubitemid 2162041)
12. Garnett GP, Cousens S, Hallett TB, Steketee R, Walker N (2011) Mathematical models in the evaluation of health programmes. Lancet 378: 515-525.
13. Grassly NC, Fraser C (2008) Mathematical models of infectious disease transmission. Nat Rev Microbiol 6: 477-487. (Pubitemid 351972134)
14. Guan P, Howell-Jones R, Li N, Bruni L, de Sanjose S, Franceschi S, Clifford GM (2012) Human papillomavirus types in 115,789 HPV-positive women: a meta-analysis from cervical infection to cancer. Int J Cancer 131: 2349-2359.
15. Hoare A, Regan DG, Wilson DP (2008) Sampling and sensitivity analyses tools (SaSAT) for computational modelling. Theor Biol Med Model 5: 4.
16. Hughes JP, Garnett GP, Koutsky L (2002) The theoretical population-level impact of a prophylactic human papilloma virus vaccine. Epidemiology 13: 631-639. (Pubitemid 44698466)
17. Jit M, Chapman R, Hughes O, Choi YH (2011) Comparing bivalent and quadrivalent human papillomavirus vaccines: economic evaluation based on transmission model. BMJ 343: d5775.
18. Keeling MJ, Rohani P (2008) Modeling infectious diseases in humans and animals. Princeton University Press: Princeton, USA.
19. Kim JJ, Kuntz KM, Stout NK, Mahmud S, Villa LL, Franco EL, Goldie SJ (2007a) Multiparameter calibration of a natural history model of cervical cancer. Am J Epidemiol 166: 137-150. (Pubitemid 47227293)
20. Kim JJ, ndres-Beck B, Goldie SJ (2007b) The value of including boys in an HPV vaccination programme: a cost-effectiveness analysis in a low-resource setting. Br J Cancer 97: 1322-1328. (Pubitemid 350035812)
21. Kretzschmar M, De Wit GA, Smits LJ, van de Laar MJ (2002) Vaccination against hepatitis B in low endemic countries. Epidemiol Infect 128: 229-244. (Pubitemid 34413996)
22. Li N, Franceschi S, Howell-Jones R, Snijders PJ, Clifford GM (2011) Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: variation by geographical region, histological type and year of publication. Int J Cancer 128: 927-935.
23. Liljeros F, Edling CR, Nunes Amaral LA (2003) Sexual networks: implications for the transmission of sexually transmitted infections. Microbes Infect 5: 189-196. (Pubitemid 36316061)
24. McCredie MR, Sharples KJ, Paul C, Baranyai J, Medley G, Jones RW, Skegg DC (2008) Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study. Lancet Oncol 9: 425-434.
25. Mesri EA, Cesarman E, Boshoff C (2010) Kaposi's sarcoma and its associated herpesvirus. Nat Rev Cancer 10: 707-719.
26. Mossong J, Hens N, Jit M, Beutels P, Auranen K, Mikolajczyk R, Massari M, Salmaso S, Tomba GS, Wallinga J, Heijne J, Sadkowska-Todys M, Rosinska M, Edmunds WJ (2008) Social contacts and mixing patterns relevant to the spread of infectious diseases. PLoS Med 5: e74.
27. Rodriguez AC, Schiffman M, Herrero R, Hildesheim A, Bratti C, Sherman ME, Solomon D, Guillen D, Alfaro M, Morales J, Hutchinson M, Katki H, Cheung L, Wacholder S, Burk RD (2010) Longitudinal study of human papillomavirus persistence and cervical intraepithelial neoplasia grade 2/3: critical role of duration of infection. J Natl Cancer Inst 102: 315-324.
28. Taira AV, Neukermans CP, Sanders GD (2004) Evaluating human papillomavirus vaccination programs. Emerg Infect Dis 10: 1915-1923. (Pubitemid 39458555)
29. Titman AC, Sharples LD (2010) Semi-Markov models with phase-type sojourn distributions. Biometrics 66: 742-752.
30. Toni T, Welch D, Strelkowa N, Ipsen A, Stumpf MP (2009) Approximate Bayesian computation scheme for parameter inference and model selection in dynamical systems. J R Soc Interface 6: 187-202.
31. Uhry Z, Hedelin G, Colonna M, Asselain B, Arveux P, Rogel A, Exbrayat C, Guldenfels C, Courtial I, Soler-Michel P, Molinie F, Eilstein D, Duffy SW (2010) Multi-state Markov models in cancer screening evaluation: a brief review and case study. Stat Methods Med Res 19: 463-486.
32. van Oortmarssen GJ, Habbema JD (1991) Epidemiological evidence for age-dependent regression of pre-invasive cervical cancer. Br J Cancer 64: 559-565.